Sinopharm
1099.HK
#2828
Rank
โ‚น572.27 B
Marketcap
โ‚น183.38
Share price
1.16%
Change (1 day)
-12.82%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚น7.956 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.956 Trillion. In 2025 the company made a revenue of โ‚น7.956 Trillion an increase over the revenue in the year 2024 that were of โ‚น7.751 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚น7.956 T2.65%
2024โ‚น7.751 T-5.1%
2023โ‚น8.167 T5.42%
2022โ‚น7.747 T-2.1%
2021โ‚น7.913 T16.85%
2020โ‚น6.772 T14.95%
2019โ‚น5.891 T21.52%
2018โ‚น4.848 T5.93%
2017โ‚น4.576 T27.22%
2016โ‚น3.597 T5.37%
2015โ‚น3.414 T9.14%
2014โ‚น3.128 T17.22%
2013โ‚น2.668 T25.94%
2012โ‚น2.118 T34.61%
2011โ‚น1.574 T55.34%
2010โ‚น1.013 T35.79%
2009โ‚น746.24 B37.56%
2008โ‚น542.49 B31.43%
2007โ‚น412.77 B40.26%
2006โ‚น294.29 B